Loading...
Last submissions
-
Thomas Brodowicz, Bernadette Liegl-Atzwanger, Nicolas Penel, Olivier Mir, Jean Yves Blay, et al.. Assessing prognostic and predictive biomarkers of regorafenib response in patients with advanced soft tissue sarcoma: REGOSARC study. Cancers, 2020, 12 (12), pp.1-12. ⟨10.3390/cancers12123746⟩. ⟨hal-03109189⟩
-
-
-
Thibaut Pressat Laffouilhère, Julien Grosjean, Jacques Bénichou, Stéfan J. Darmoni, Lina F. Soualmia. OntoBioStat: Supporting Causal Diagram Design and Analysis. Studies in Health Technology and Informatics, 2022, Studies in Health Technology and Informatics, 294, pp.302-306. ⟨10.3233/SHTI220463⟩. ⟨hal-03984907⟩
-
Wendy Bijoux, Emilie Cordina-Duverger, Soumaya Balbolia, Pierre-Jean Lamy, Xavier Rebillard, et al.. Occupation and prostate Cancer risk: results from the epidemiological study of prostate cancer (EPICAP). Journal of Occupational Medicine and Toxicology, 2022, 17 (1), pp.5. ⟨10.1186/s12995-022-00346-2⟩. ⟨hal-03687349⟩
-
-
Antonio Di Meglio, Julie Havas, Davide Soldato, Daniele Presti, Elise Martin, et al.. Development and Validation of a Predictive Model of Severe Fatigue After Breast Cancer Diagnosis: Toward a Personalized Framework in Survivorship Care. Journal of Clinical Oncology, 2022, 40 (10), pp.1111--1123. ⟨10.1200/JCO.21.01252⟩. ⟨hal-03855945⟩
-
Antonio Di Meglio, Julie Havas, Arnauld S. Gbenou, Elise Martin, Mayssam El-Mouhebb, et al.. Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy. Journal of Clinical Oncology, 2022, 40 (27), pp.3190--3204. ⟨10.1200/JCO.21.00277⟩. ⟨hal-03855946⟩
-
-
-
Paul Gougis, Arthur Géraud, Marc Hilmi, Aurore Vozy, Luca Campedel, et al.. Cytochrome P-450-mediated herb and food–drug interactions can be identified in cancer patients through patient self-reporting with a tablet application: results of a prospective observational study. ESMO Open, 2022, 7 (6), ⟨10.1016/j.esmoop.2022.100650⟩. ⟨hal-03950147⟩
-
-
Francois-Xavier Danlos, Matthieu Texier, Bastien Job, Severine Mouraud, Lydie Cassard, et al.. Genomic Instability and Pro-Tumoral Inflammation are associated with Primary Resistance to Anti-PD1 + Anti-Angiogenesis in Malignant Pleural Mesothelioma. Cancer Discovery, 2023, pp.OF1-OF22. ⟨10.1158/2159-8290.CD-22-0886⟩. ⟨hal-03972355⟩
-
-
Pierre Mordant, Solenn Brosseau, Bernard Milleron, Nicola Santelmo, Séverine Fraboulet-Moreau, et al.. Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study. Clinical Lung Cancer, 2023, 24 (1), pp.1-10. ⟨10.1016/j.cllc.2022.08.013⟩. ⟨hal-03800571⟩
-
Matthieu Duchmann, Jean-Baptiste Micol, Nicolas Duployez, Emmanuel Raffoux, Xavier Thomas, et al.. Prognostic significance of concurrent gene mutations i n intensively treated patients with IDH-mutated AML: an ALFA study. Blood, 2021, 137 (20), pp.2827-2837. ⟨10.1182/blood.2020010165⟩. ⟨hal-03604929⟩
-
Dorian Culié, Renaud Schiappa, Anouchka Modesto, Julien Viotti, Emmanuel Chamorey, et al.. Upfront surgery or definitive radiotherapy for p16+ oropharyngeal cancer. A GETTEC multicentric study. EJSO - European Journal of Surgical Oncology, 2021, In press, ⟨10.1016/j.ejso.2020.12.011⟩. ⟨hal-03166902⟩
-
Laurie Saloner Dahan, Roch Giorgi, Sébastien Vergez, Ludovic Le Taillandier de Gabory, Valérie Costes-Martineau, et al.. Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases. EJSO - European Journal of Surgical Oncology, 2021, 47 (6), pp.1376-1383. ⟨10.1016/j.ejso.2020.11.123⟩. ⟨hal-03049061⟩
-
-